関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Trifluoroacetic acid | HCID 6422 | — |
| 反応物 | N-(tert-butoxycarbonyl)piperidine | HCID 7010304 | — |
| 反応物 | Benzeneacetic acid, alpha-diazo-, methyl ester | HCID 53436974 | — |
| 触媒 | Tetrakis[(S)-(-)-N-(P-dodecylphenylsulfonyl)prolinato]dirhodium(II) | HCID 10986130 | — |
| 溶媒 | 2,3-Dimethylbutane | HCID 6589 | — |
| 生成物 | methyl (S)-phenyl((R)-piperidin-2-yl)acetate | HCID 6101852 | 49% |
反応手順
As shown above in Scheme V and Table III, Rh2 (S-DOSP)4 7 catalyzed decomposition of methyl phenyldiazoacetate 9a in the presence of N-BOC-piperidine (15, 4 equiv) in 2,3-dimethylbutane at room temperature followed by treatment with trifluoroacetic acid resulted in the formation of a mixture of threo and erythro methyphenidate, 16 and 17, in 49% yield. However, the threo isomer 16 was the minor diastereomer and was formed in only 34% ee. The combined yield of 16 and 17 was improved to 86% by using the N-BOC-peperidine as the limiting reactant. This result is different to what was observed with N-BOC-pyrrolidine, which gave bis C—H insertion when an excess of phenyldiazoacetate was used. A major improvement in enantioselectivity and diastereoselectivity was achieved by carrying out the reaction with the Rh2 [bridged(S-TBSP)2]2 8 catalyst. The ratio of 16:17 (73% yield) was improved to 2.5:1 and (2R, 2′R)-threo isomer 16 was formed in 86% ee and 52% isolated yield. As shown in Table III, Rh2 [bridged(S-TBSP)2]2 8 results in opposite asymmetric induction to Rh2 (S-DOSP)4 7, and, in the reaction of 9a and 15 catalyzed by 8, the biologically active enantiomer of threo-methylphenidate is formed.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07109343B2 |
|---|
| 出典データセット | uspto-grants-2006_09 |
|---|
| ORD ID | ord-d22cb99075e2434dadbe9fe2da40a417 |
|---|
| 出典メモ | uspto-grants-2006_09 |
|---|